We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Optibiotix Health Plc | LSE:OPTI | London | Ordinary Share | GB00BP0RTP38 | ORD 2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 18.25 | 17.50 | 19.00 | 18.25 | 18.25 | 18.25 | 144,329 | 07:39:19 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Noncomml Resh Organizations | 457k | 2.59M | 0.0284 | 6.43 | 16.64M |
Date | Subject | Author | Discuss |
---|---|---|---|
14/8/2017 12:56 | Thanks for posting the interview. I didn't feel that it told us much that we didn't already know, apart from something of a bit of a negative vibe. What I mean is, that SoH has pretty well hinted that we shouldn't expect much in the way of RNS's till the end of the Summer, IF I've understood that correctly. I always got the feeling that it was 'news soon, at any moment'. IF I've understood correctly, I could see the price drifting more. Am I alone in this/have I misunderstood SoH's comments? I really don't want to give the Shorters ammunition here, as I'm heavily invested (ha ha spill check came up with Incested'), to the the annoyance of my long suffering wife. John | 2350220 | |
14/8/2017 12:55 | Only it won't be statins. Question for anyone - we've had European agreement, New Zealand, Tata for Asia. Wonder who will launch the statin alternative in uk? S | shrewdmole | |
14/8/2017 12:50 | Exactly Someuwin | joyjoy13 | |
14/8/2017 12:17 | I totally agree, but from the sound of that interview he expects the majority to close between September and 2018! | f3rdinand | |
14/8/2017 12:05 | Ferdi I'm not bothered how quickly they get sorted. I'm more bothered that the RIGHT deals are done on the RIGHT terms. Soh has said time and again he could sign deals daily but they wouldn't be on his terms. The exclusivity payments and some income now will keep us topped up for funds. At some point soon you will see Tata launch and I'd hazard a guess a Central American major. In the meantime we are on royalties for product and sales and that will only grow. This isn't a share to monitor daily imho. It's one to but and look in every now and again. S | shrewdmole | |
14/8/2017 12:00 | Thanks for the link joy! Let's see how many of the 39 deals get closed before 2018! | f3rdinand | |
14/8/2017 11:43 | Obviously schools out at the moment and the stupid kids this summer are bored so decided to play here instead! Go away, your not wanted! | joyjoy13 | |
14/8/2017 11:41 | Don't know if already posted, apologies if it has. But all I can say to all the posters on this board, IMHO, IF YOU DON'T UNDERSTAND BY NOW YOU NEVER WILL SO PLEASE PLEASE PLEASE BUGGAR OFF ALL PROPHETS OF DOOM AND GLOOM. Thank you for your concern about my financial wellbeing but I take full responsibility, I don't want or need your input, I know my own mind! INTERVIEW: Optibiotix Health Plc High Commercial Interest Turning To Fruition hxxps://www.director | joyjoy13 | |
14/8/2017 11:12 | Parob, agreed. | rafboy | |
14/8/2017 11:09 | It sounds pretty obvious to me that SOH knows exactly what lies ahead and would hate LTHs to miss out having waited so patiently.If just a third of those 39 potential deals close out between Aug and end of the year, we'll be laughing. | parob | |
14/8/2017 11:04 | A very good interview IMHO. Lots of opportunities going forward. I think that interview was to steady the ship and remind investors we are only at the start of the commercialisation phase. Talkingtrading, it is clear you don't believe what SOH is saying so why are you here? Time to jog on my friend. | rafboy | |
14/8/2017 10:39 | Very good interview from SoH. | trotterstrading | |
14/8/2017 10:23 | New SOH interview just out on Directors Talk. INTERVIEW: Optibiotix Health Plc High Commercial Interest Turning To Fruition Optibiotix Health Plc (LON:OPTI) CEO Stephen O’Hara talks to DirectorsTalk about the recent share price movement. Stephen also talks about the potential for 39 RNS’s that could be announced over the coming months as opportunities turn to fruition. | parob | |
14/8/2017 09:10 | Amazon, have you collected your repeat prescription today??? | europa79 | |
14/8/2017 08:14 | Good find lounge, shows TATA are serious about the Microbiome. As I've said before trust your research and if you don't trust your own research then trust the DD of multi-nationals with a team of experts running the run over the company and products for 12months or more!! | trotterstrading | |
14/8/2017 08:11 | could be an interesting week here if the weakness plays out | tsmith2 | |
13/8/2017 23:48 | TATA Chemicals provides glimpse into future production of food supplements — found this interesting, and inline with their release of Slimbiome products later this year — hxxp://m.economictim | loungeact | |
13/8/2017 23:18 | Up tomorrow? | zebbo |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions